Episurf Medical Q2: Continues to prepare for the next phase - Redeye

Redeye comments on Episurf’s Q2 report and notes a quarter in line with our expectations both financially and in terms of activities. The company is preparing for a more intensified commercial phase, and we see several exciting activities in the coming months. We reiterate our fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/848705/episurf-medical-q2-2022-continues-to-prepare-for-the-next-phase?utm_source=finwire&utm_medium=RSS